The miR-486-5p plays a causative role in prostate cancer through negative regulation of multiple tumor suppressor pathways

Jemal, 2015, Cancer statistics, 2015, CA Cancer J Clin, 65, 5, 10.3322/caac.21254

Gray, 2008, Translating insights from the cancer genome into clinical practice, Nature, 452, 553, 10.1038/nature06914

Flohr, 2015, DNA-repair defects and olaparib in metastatic prostate cancer, N Engl J Med, 373, 1697, 10.1056/NEJMoa1506859

Croce, 2009, Causes and consequences of microRNA dysregulation in cancer, Nat Rev Genet, 10, 704, 10.1038/nrg2634

Croce, 2013, Clinical applications for microRNAs in cancer, Clin Pharmacol Ther, 93, 98, 10.1038/clpt.2012.192

Golub, 2005, MicroRNA expression profiles classify human cancers, Nature, 435, 834, 10.1038/nature03702

Singh, 2016, Exploiting nanotechnology for the development of microRNA-based cancer therapeutics, J Biomed Nanotechnol, 12, 28, 10.1166/jbn.2016.2172

Visakorpi, 2007, MicroRNA expression profiling in prostate cancer, Cancer Res, 67, 6130, 10.1158/0008-5472.CAN-07-0533

Visakorpi, 2015, MiR-1247-5p is overexpressed in castration resistant prostate cancer and targets MYCBP2, Prostate, 75, 798, 10.1002/pros.22961

Jeon, 2013, Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer, Proc Natl Acad Sci U S A, 110, 15043, 10.1073/pnas.1307107110

Ma, 2016, Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer, Oncotarget, 7, 34011, 10.18632/oncotarget.8514

Tan, 2011, Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer, Clin Cancer Res, 17, 2657, 10.1158/1078-0432.CCR-10-3152

Jung, 2012, miR-486-5p induces replicative senescence of human adipose tissue-derived mesenchymal stem cells and its expression is controlled by high glucose, Stem Cells Dev, 21, 1749, 10.1089/scd.2011.0429

Yang, 2014, MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in breast cancer cells, Tumour Biol, 35, 11137, 10.1007/s13277-014-2412-0

Olson, 2010, Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486, Proc Natl Acad Sci U S A, 107, 4218, 10.1073/pnas.1000300107

Hu, 2012, Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486, Kidney Int, 82, 401, 10.1038/ki.2012.84

Ittmann, 1997, PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer, Science, 275, 1943, 10.1126/science.275.5308.1943

Kobayashi, 2016, MiR-142-5p and miR-486-5p as biomarkers for early detection of chronic antibody-mediated rejection in kidney transplantation, Biomarkers, 1

Bhatia, 2015, MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors, Blood, 125, 1302, 10.1182/blood-2014-06-581926

Shen, 2010, Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer, J Clin Oncol, 28, 1721, 10.1200/JCO.2009.24.9342

Jiang, 2010, Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers, Int J Cancer, 127, 2870, 10.1002/ijc.25289

Cheng, 2008, MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN, Cancer Res, 68, 425, 10.1158/0008-5472.CAN-07-2488

Hui, 2012, MiR-214 targets beta-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma, PLoS One, 7, e44206, 10.1371/journal.pone.0044206

Shi, 2015, miR-483-5p and miR-486-5p are down-regulated in cumulus cells of metaphase II oocytes from women with polycystic ovary syndrome, Reprod Biomed Online, 31, 565, 10.1016/j.rbmo.2015.06.023

Esmaeli, 2015, Distinct pathways in the pathogenesis of sebaceous carcinomas implicated by differentially expressed microRNAs, JAMA Ophthalmol, 133, 1109, 10.1001/jamaophthalmol.2015.2310

Dong, 2013, Deletion of hepatic FoxO1/3/4 genes in mice significantly impacts on glucose metabolism through downregulation of gluconeogenesis and upregulation of glycolysis, PLoS One, 8, e74340, 10.1371/journal.pone.0074340

Burgering, 2015, FOXO target gene CTDSP2 regulates cell cycle progression through Ras and p21(Cip1/Waf1), Biochem J, 469, 289, 10.1042/BJ20140831

Lees, 2008, FoxO3a preferentially induces p27Kip1 expression while impairing muscle precursor cell-cycle progression, Muscle nerve, 37, 84, 10.1002/mus.20897

Sikes, 2012, Increased TGF-beta1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signaling, Prostate, 72, 1339, 10.1002/pros.22482

Danielpour, 2009, Critical role of Smad2 in tumor suppression and transforming growth factor-beta-induced apoptosis of prostate epithelial cells, Cancer Res, 69, 2185, 10.1158/0008-5472.CAN-08-3961

Semenza, 2014, Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology, Annu Rev Pathol, 9, 47, 10.1146/annurev-pathol-012513-104720

Ratcliffe, 1999, The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis, Nature, 399, 271, 10.1038/20459

Patel, 2015, HIF1alpha expression under normoxia in prostate cancer--which pathways to target?, J Urol, 193, 763, 10.1016/j.juro.2014.10.085

Le QT Giaccia, 2009, Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation, Mol Cell, 35, 856, 10.1016/j.molcel.2009.09.006

Ragoussis, 2008, hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer, Clin Cancer Res, 14, 1340, 10.1158/1078-0432.CCR-07-1755

Ricci, 2011, miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity, Cell Death Differ, 18, 465, 10.1038/cdd.2010.119

Meng, 2014, Hypoxia-induced miR-210 in epithelial ovarian cancer enhances cancer cell viability via promoting proliferation and inhibiting apoptosis, Int J Oncol, 44, 2111, 10.3892/ijo.2014.2368

Di, 2015, MiR-199a inhibits the angiogenic potential of endometrial stromal cells under hypoxia by targeting HIF-1alpha/VEGF pathway, Int J Clin Exp Pathol, 8, 4735

Kuo, 2010, MicroRNA-519c suppresses hypoxia-inducible factor-1alpha expression and tumor angiogenesis, Cancer Res, 70, 2675, 10.1158/0008-5472.CAN-09-2448

Russo, 2010, miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells, J Cell Physiol, 4, 242

Takahashi, 2008, Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster, Cancer Res, 68, 5540, 10.1158/0008-5472.CAN-07-6460

Huang, 2012, TCF12 protein functions as transcriptional repressor of E-cadherin, and its overexpression is correlated with metastasis of colorectal cancer, J Biol Chem, 287, 2798, 10.1074/jbc.M111.258947